CTLA4-FasL, the Hexameric Targeted FasL Fusion Protein, As Potential Novel Treatment for DLBCL

Autor: Aronin, Alexandra *, Ben Gigi-Tamir, Liat *, Makdasi, Efi *, Amsili, Shira *, Ben David, Shlomi *, Avraham, Ortal *, Sagiv, Yehudith Jitka *, Gozlan, Yosi Meir *, Shani, Noam *, Dranitzki Elhalel, Michal *
Zdroj: In Blood 8 December 2017 130 Supplement 1:4107-4107
Databáze: ScienceDirect